Partnerships & Joint Ventures
-
Repositive expands CRO network with Pharmatest partnership
Cambridge-based Repositive, which claims “the world’s largest directory of preclinical cancer models,” has expanded its global network of contract... Read More
-
New Oxbridge alliance to develop next-generation CAR-T cell therapies
PhoreMost, the Cambridge biopharma company dedicated to developing drugs against intractable disease targets, has entered into a discovery... Read More
-
Bango and Microsoft unite to boost new Xbox cloud gaming subscriptions
Cambridge mobile payment technology world leader Bango has reinforced its partnership with Microsoft to open-up access to Xbox subscriptions and... Read More
-
Sosei Heptares cashes in on new Cambridge-California business enterprise
Cambridge-based Sosei Heptares and Aditum Bio in California have created a new company – Tempero Bio – to advance the clinical development of the... Read More
-
Cambridge-Sydney alliance advances promising cancer immunotherapy
Biosceptre in Cambridge UK has teamed up with Australian cancer tech trailblazer Carina Biotech to advance a promising oncology immunotherapy.... Read More
-
Cambridge-Swiss alliance produces new microfluidic driver
Cambridge micropump manufacturer TTP Ventus has revealed a UK-Swiss technology alliance to create a compact high-performance microfluidic driver. TTP... Read More
-
Perfect STORM as partners explore role of RNA epigenetics in epilepsy
STORM Therapeutics in Cambridge and Dublin based FutureNeuro have joined forces to explore new treatment options for people with epilepsy.... Read More
-
Crescendo enters collaboration to create cutting-edge oncology treatment
Cambridge-based Crescendo Biologics Ltd, the drug developer of novel, targeted T cell enhancing therapeutics has signed a pre-clinical collaboration... Read More
-
Medical alliance to advance technology push
Plextek Services and Design Momentum (DM) have announced a strategic partnership to develop scientific instruments and laboratory equipment for life... Read More
-
Healx fights rare disorder via new global alliance
Healx, the AI-powered technology business repurposing drugs to fight rare diseases, has forged a new global alliance that could hold significant... Read More
-
Eagle in rudest of health after tie-up with hygiene specialist
UK-based global health and hygiene company RB is collaborating with Eagle Genomics in Cambridge in a research project designed to simplify... Read More
-
Cambridge startup inspires AI-led approach to cancer trials
Cambridge Cancer Genomics is leveraging its AI platform in a new partnership designed to more accurately target tumours in precision clinical trials... Read More
-
Arecor targets oncology and rare orphan diseases in US alliance
Cambridge biopharma business Arecor has extended its multi-product collaboration with a US-based clinical stage biotechnology company. Under the... Read More
-
Italian pioneer works with TTP to boost global health diagnostics
Technology hothouse TTP is at the heart of a European initiative to revolutionise in vitro diagnostic medical device (IVD) technology to boost... Read More
-
Heart and Seoul as Avacta launches Korean JV
Cambridge based BioMedTech business Avacta Group has joined forces with Daewoong Pharmaceutical to establish a significant joint venture in South... Read More
-
Healx and Boehringer battle rare neurological diseases
Cambridge-based Healx and German powerhouse Boehringer Ingelheim have joined forces to identify indications related to rare neurological diseases... Read More
-
Cambridge duo develop novel cell technology
Life sciences influencer Abcam and Cambridge neighbour SomaServe, a pharma service and specialist reagent business exploiting PolyNaut Technology,... Read More
-
Abcodia and AstraZeneca China fight for earlier cancer detection
Cambridge UK business Abcodia, a leader in early cancer detection, has formed a strategic partnership with AstraZeneca China focusing on the early... Read More
-
PhoreMost and Sentinel extend cancer collaboration
PhoreMost, the Cambridge biopharma company dedicated to drugging ‘undruggable’ disease targets, and Sentinel Oncology, have expanded a collaboration... Read More
-
Sphere Fluidics hits a fresh Peak with cell analysis collaboration
Sphere Fluidics, which is commercialising single cell analysis systems underpinned by its patented picodroplet technology, and Peak Analysis and... Read More